Bill > SF0019

This bill expands the methods by which epinephrine, a medication used to treat severe allergic reactions (anaphylaxis), can be administered, moving beyond just auto-injectors to include nasal sprays and any other device or method approved by the U.S. Food and Drug Administration (FDA). It updates definitions to reflect these broader options, ensuring that schools and other entities can utilize the most effective and available treatments. The bill also requires relevant state departments to create rules and guidelines for the implementation of these new administration methods, with most provisions taking effect on July 1, 2026, while the rule-making sections become effective immediately upon the bill becoming law.

Health and Social Services

https://www.wyoleg.gov/Legislation/2026/SF0019